Skip to main content

Advertisement

Log in

Managing benzodiazepine withdrawal during pregnancy: case-based guidelines

  • Case Report
  • Published:
Archives of Women's Mental Health Aims and scope Submit manuscript

Abstract

Substance use disorders during pregnancy pose serious risks for both the mother and the fetus, demanding careful monitoring by the patient’s medical providers. Sedative-hypnotic use, in particular, is common but remains poorly studied. Management of withdrawal from chronic benzodiazepine use during pregnancy presents unique challenges to the treating physician. We present two pregnant patients with dependence on sedative-hypnotic agents, outline principles of benzodiazepine withdrawal, and suggest guidelines for detoxification during pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Bellantuono C, Tofani S, Di Sciascio G et al (2012) Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview. Gen Hosp Psychiatry 35:3–8

    Article  PubMed  Google Scholar 

  • Burd L (2004) Fetal alcohol syndrome. Am J of Med Gen Part C (Semin Med Genet) 127C:1–2

    Article  Google Scholar 

  • Cassidy EM, O’Sullivan I, Bradshaw P et al (2012) Symptom-triggered benzodiazepine therapy for alcohol withdrawal syndrome in the emergency department: a comparison with the standard fixed dose benzodiazepine regimen. Emerg Med J 29(10):802–804

    Article  PubMed  Google Scholar 

  • Dolovich LR, Addis A, Regis JM et al (1998) Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case–control studies. BMJ 317:839–843

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Enato E, Moretti M, Koren G (2001) The fetal safety of benzodiazepines: an updated meta-analysis. J Obstet Gybnaecol Can 33(1):46–48

    Google Scholar 

  • Foy A, March S, Dinkwater V (1988) Use of an objective clinical scale in the assessment and management of alcohol withdrawal in a large general hospital. Alcohol Clin Exp Res 12(3):360–364

    Article  CAS  PubMed  Google Scholar 

  • Iqbal MM, Sobhan T, Ryals T (2002) Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatr Serv 53(1):39–49

    Article  PubMed  Google Scholar 

  • Long LP, Johnson B (2000) Addiction: part I. Benzodiazepines—side effects, abuse risk and alternatives. Am Fam Physician 61(7):2121–2128. http://www.aafp.org/afp/2000/0401/p2121.html

  • Mayo-Smith MF, Beecher LH, Fischer TL et al (2004) Management of alcohol withdrawal delirium. An evidence-based practice guideline. Atch Int Med 164(13):1405–1412

    CAS  Google Scholar 

  • Rada P, Hoebel BG (2005) Acetylcholine in the accumbens is decreased by diazepam and increased by benzodiazepine withdrawal: a possible mechanism for dependency. Eur J Pharmacol 508(1–3):131–138

    Article  CAS  PubMed  Google Scholar 

  • Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality (2010) Results from the 2010 National Survey on Drug Use and Health: summary of national findings, NSDUH series H-41, HHS publication no. (SMA) 11–4658. Substance Abuse and Mental Health Services Administration, Rockville, MD. http://www.samhsa.gov/data/NSDUH/2k10ResultsRev/NSDUHresultsRev2010.htm#5.8

  • Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality (2012a) Results from the 2011 National Survey on Drug Use and Health: summary of national findings, NSDUH series H-44, HHS publication no. (SMA) 12–4713. Substance Abuse and Mental Health Services Administration, Rockville, MD

  • Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality (2012b) The TEDS report: admissions reporting benzodiazepine and narcotic pain reliever abuse at treatment entry. Substance Abuse and Mental Health Services Administration, Rockville, MD

  • Sullivan JT, Sykora K, Schneiderman J et al (1989) Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment For Alcohol Scale (CIWA-Ar). Br J Addict 84(11):1353–1357

    Article  CAS  PubMed  Google Scholar 

  • Vinkers CH and Olivier B (2012) Mechanisms underlying tolerance after long-term benzodiazepine use: a future for subtype-selective GABAA receptor modulators? Adv Pharmacol Sci 2012:416864. doi:10.1115/2012/416864

  • Wikner BN, Stiller CO, Bergman U et al (2007) Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol Drug Saf 16:1203–1210

    Article  PubMed  Google Scholar 

  • Wisner KL, Zarin DA, Holmboe ES (2000) Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry 157:1933–1940

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Priya Gopalan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gopalan, P., Glance, J.B. & Azzam, P.N. Managing benzodiazepine withdrawal during pregnancy: case-based guidelines. Arch Womens Ment Health 17, 167–170 (2014). https://doi.org/10.1007/s00737-013-0388-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00737-013-0388-1

Keywords

Navigation